Its expression is particularly upregulated in colorectal and gastric cancer patients, where it is primarily secreted by tumor epithelial cells, whereas its receptor, ST2L, is predominantly expressed in intestinal epithelial stromal cells [81,123,124]. Here, IL1RL1 is linked to neoplasm.